Company Filing History:
Years Active: 2000-2002
Title: Max Werner Scheiwe: Innovator in Pharmaceutical Formulations
Introduction
Max Werner Scheiwe is a notable inventor based in Maulburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical formulations and compositions aimed at treating various skin ailments and malaria.
Latest Patents
Scheiwe holds 3 patents that showcase his innovative approach to pharmaceutical formulations. His latest patents include a topical formulation of alkyl- and phenyl-pyridone, which is designed for the treatment and prevention of skin ailments such as fibriotic lesional tissues, contiguous warts, contact dermatitis, and keloids. This formulation utilizes a substituted pyridone as the active ingredient, specifically 5-methyl-1-phenyl-2-(1H)pyridone (Pirfenidone), combined with various excipients to enhance its effectiveness. Another significant patent involves a pharmaceutically active composition containing artemisinine and/or its derivatives, which are effective against malaria parasites, particularly against multiresistant strains.
Career Highlights
Throughout his career, Scheiwe has worked with reputable companies such as Mepha AG and Melpha AG. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Scheiwe has collaborated with notable professionals in the field, including Shitotomo Yamauchi and Thomas Villiger. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
Max Werner Scheiwe is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly improve treatment options for various medical conditions. His innovative contributions continue to shape the landscape of pharmaceutical science.